SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 55.80
+1.35 (2.48%)
Jul 20, 2026, 4:00 PM EDT
SMO ClinPlus CO.,LTD. Market Cap
SMO ClinPlus CO.,LTD. has a market cap or net worth of 4.41 billion as of July 20, 2026. Its market cap has increased by 48.82% in one year.
Market Cap
4.41B
Enterprise Value
3.83B
Revenue
860.07M
Ranking
n/a
PE Ratio
38.51
Stock Price
55.80
ChartMarket Cap Chart
Since May 17, 2022, SMO ClinPlus CO.,LTD.'s market cap has decreased from 4.48B to 4.41B, a decrease of -1.56%. That is a compound annual growth rate of -0.38%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 4.41B | 7.23% |
| Dec 31, 2025 | 4.11B | 91.80% |
| Dec 31, 2024 | 2.14B | -44.81% |
| Dec 29, 2023 | 3.88B | 32.91% |
| Dec 30, 2022 | 2.92B | -34.76% |
| May 17, 2022 | 4.48B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Amoy Diagnostics | 6.79B |
| Beijing Strong Biotechnologies,Inc. | 6.67B |
| Shanghai Runda Medical Technology | 5.85B |
| Maccura Biotechnology Co.Ltd | 5.48B |
| Cowealth Medical China | 4.10B |
| Shanghai Labway Clinical Laboratory | 3.53B |
| Medicalsystem Biotechnology | 3.34B |
| Guangdong Hybribio Biotech | 3.29B |